DepYmed
Developer of potent inhibitors of the enzyme designed to offer therapeutics for cancer and rare diseases. The company provides a portfolio of novel small molecules with copper-chelating properties tha...
Valuation
$0
Share Price
N/A
Total Raised
$14.3M
Last Round
N/A